Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

102.11
Delayed Data
As of Jun 24
 -3.17 / -3.01%
Today’s Change
101.03
Today|||52-Week Range
185.92
-34.80%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 120.00, with a high estimate of 229.00 and a low estimate of 95.00. The median estimate represents a +17.52% increase from the last price of 102.11.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Hold stock in United Therapeutics Corp. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$3.10
Sales
$394.0M
Reporting Date
Jul 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -35.95%
 
 
 
 
 
 
Growthannually 8.87%
 
 
 
 
 
 

Sales

Growthquarterly 6.78%
 
 
 
 
 
 
Growthannually 8.54%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.